WS #16770
The cannabis sector is experiencing a violent repricing following the announcement that Organigram will acquire Aurora Cannabis for $7.80 per share, an 85% premium to the last close. Trading has resumed for both tickers, with Aurora poised for a significant gap-up. This deal is sparking broader M&A speculation in the fragmented cannabis space, driving volume and volatility. It stands in stark contrast to the broader market's risk-off sentiment, highlighting a niche rotation into distressed asset arbitrage.
Cannabis M&A and Sector Rotation
The cannabis sector is experiencing a violent repricing following the announcement that Organigram will acquire Aurora Cannabis for $7.80 per share, an 85% premium to the last close. Trading has resumed for both tickers, with Aurora poised for a significant gap-up. This deal is sparking broader M&A speculation in the fragmented cannabis space, driving volume and volatility. It stands in stark contrast to the broader market's risk-off sentiment, highlighting a niche rotation into distressed asset arbitrage.